Evidence map›Paper›PMID 37645335›Full record

ArticleOpen research Europe2022

Ethical consumption: why should we understand it as a social practice within a multilevel framework?

Sara Karimzadeh, Magnus Boström

Abstract read
In one paragraph

Article in Open research Europe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sara KarimzadehSchool of Humanities, Education and Social Sciences, Örebro University, Örebro, Örebro, 701 82, Sweden.ORCID https://orcid.org/0000-0003-0154-7502
Magnus BoströmSchool of Humanities, Education and Social Sciences, Örebro University, Örebro, Örebro, 701 82, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article discusses the importance of a multilevel and intertwined understanding of ethical consumption given its conjunction with other social practices. Although the literature on ethical consumption is vast, the role of sociotechnical regimes including technological and cultural elements, infrastructure, market and regulation has been mainly overlooked in this literature. This may be so because ethical consumption practices that refer to other-oriented consumption practices are mainly considered in the view of the motivations and preferences of individual consumers. Due to the insufficiency of individualistic approaches in explaining stimulators and inhibitors of ethical consumption, there might be "various constraints" and "competing demands" in society which limit the formation of "ethical consumption". Therefore, to avoid an oversimplified view of ethical consumption, this paper contributes with a theoretical discussion on combining social practice theory (SPT) with a multi-level perspective (MLP). Although the SPT is a very well-structured framework in consumption studies, the necessity of a combined approach concerns the often-insufficient attention paid to structural prerequisites of various consumption forms in social practice theories. By understanding ethical consumption practices according to a multi-level framework, the paper emphasizes the importance of structural factors at macro- and mesolevels. It also contributes attention to how ethical consumption grows due to dialectical processes between levels, showing that niche practices can simultaneously challenge and rely on existing regimes.

Indexed as

combination approach.Ethical consumption practicesmultilevel perspectivesocial practice theory

Identifiers

PMID37645335
PMCPMC10445865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.